Clinical Trials
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive Results
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July 27 as it has shown positive results in previous human trials. Undoubtedly, this is a...
News
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialisation outside the USA, excluding Greater China*. In the US, Genentech, a member of the Roche...
News
Gilead presents additional data on investigational antiviral remdesivir to treat COVID-19 at Virtual COVID-19 Conference
Gilead Sciences Inc, announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on treatment outcomes with remdesivir.
The data are being presented at the Virtual COVID-19 Conference as part...
News
Glenmark reduces price of oral antiviral FabiFlu by 27% in India
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a post marketing surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1,000 patients that are prescribed with...
Drug Research
Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API
Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient (API), used in the finished formulation to treat mild to moderate COVID-19 cases. Besides DCGI’s...
Clinical Trials
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies
Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), announces that it has entered into a Collaboration Agreement with Educell Ltd., a premier European cell therapy company....
News
Almost one third of life science companies set to begin quantum computing evaluation this year
New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third (31 percent) of life science organisations polled are set to begin quantum computing evaluation this year. A further 39 percent...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.